Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,041.02 +22.63 (+0.45%) Dow
38,072.78 +169.49 (+0.45%) Nasdaq
15,746.07 +140.58 (+0.90%) Bitcoin USD
59,101.81 +2,142.85 (+3.76%) CMC Crypto 200
1,276.64 +5.90 (+0.46%)
Viatris Inc. (VTRS)
| Previous close | 11.63 |
| Open | 11.68 |
| Bid | 11.52 x 200 |
| Ask | 11.56 x 500 |
| Day's range | 11.52 - 11.73 |
| 52-week range | 8.74 - 13.62 |
| Volume | |
| Avg. volume | 9,018,860 |
| Market cap | 13.722B |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 230.50 |
| EPS (TTM) | 0.05 |
| Earnings date | 06 May 2024 - 10 May 2024 |
| Forward dividend & yield | 0.48 (4.13%) |
| Ex-dividend date | 08 Mar 2024 |
| 1y target est | 15.71 |
ZacksViatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PR NewswireViatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, recently launched Unmind as part of its global wellbeing program, Elevate. Unmind is a leading provider of workplace mental health solutions designed by psychologists to help individuals understand and be proactive with their mental health and lead healthier, happier lives.
Insider Monkey11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
